Board of Directors

Dr. Amit Kumar, Ph.D
Dr. Amit Kumar, Ph.D Chairman, President & Chief Executive Officer

Dr. Kumar, the inventor of our Cchek™ technology, has been an investor, founder, director and CEO of several technology enterprises, both public and private. As CEO, he took CombiMatrix Corporation public and ran it for a decade while listed on the NASDAQ Global Market. He has worked in venture capital ...

Read More

Lew Titterton
Lew Titterton Lead Independent Director

Mr. Titterton previously served as a Director from August 2010 through August 2016, the last four years of which as Chairman of the Board. He also served as a Director from July 1999 to January 2003. Mr. Titterton's background is in high technology with an emphasis on health care. He ...

Read More

Dr. John Monahan, Ph.D
Dr. John Monahan, Ph.D Director

Dr. Monahan is an experienced CEO-level executive and has served on a number of biotechnology company boards over the years. He is currently a Scientific Advisory Consultant for Synthetic Biologics, Inc. (NYSE MKT: SYN) and from 2010 through 2015 he was the Sr. Executive Vice President of Research & Development ...

Read More

Bruce Johnson
Bruce Johnson Director

Mr. Johnson previously served on our Board from August 2012 until August 2016. He has been a commodity trader on the Chicago Mercantile Exchange for over 40 years. He served as a member of the board of directors of CME Group Inc. from 1998 to 2015. From 1969 to 2003, ...

Read More

Dick Williams
Dick Williams Director

Mr. Williams, an experienced businessman and entrepreneur, has served as a consultant to emerging growth companies since 1980. He currently serves as a special advisor to the Chairman and CEO of ParkerVision, Inc., a NASDAQ listed wireless technology company, in the areas of business development, acquisitions, and investment banking. Mr. ...

Read More

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Moffitt Cancer Center and ITUS Corporation Announce Scheduling of Pre-IND Meeting with the FDA for their CAR-T Therapy


ITUS Corporation to Present at Next Generation Dx Summit


Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy


Cancer Fact: 27% of global cancer deaths occur in China.